Health CareMedical Equipment and Services
  • Price (USD)250.16
  • Today's Change4.32 / 1.76%
  • Shares traded1.55m
  • 1 Year change-4.56%
  • Beta0.5306
Data delayed at least 15 minutes, as of Feb 06 2023 21:10 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through three business segments: BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including medication delivery solutions, medication management solutions, diabetes care and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products.

  • Revenue in USD (TTM)18.74bn
  • Net income in USD1.49bn
  • Incorporated1906
  • Employees77.00k
  • Location
    Becton Dickinson and CoOne Becton DriveFRANKLIN LAKES 07417-1880United StatesUSA
  • Phone+1 (201) 847-6800
  • Websitehttps://www.bd.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
BDX:NYQ since
MedKeeper LLCDeal completed28 Jul 202228 Jul 2022Deal completed2.38%93.00m
Parata Systems LLCDeal completed06 Jun 202206 Jun 2022Deal completed-0.86%1.53bn
Data delayed at least 15 minutes, as of Feb 06 2023 21:10 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
DexCom, Inc.2.79bn230.00m41.88bn6.30k202.5322.95109.7215.000.53540.53546.714.720.57732.875.11443,301.604.755.565.726.5065.9767.298.248.913.4312.920.52660.0027.0833.69-68.66--47.52--
Edwards Lifesciences Corp5.38bn1.52bn50.77bn15.70k33.678.7441.369.432.442.448.629.390.6411.358.79--18.1216.3220.6519.0479.9676.3228.2824.432.17--0.0931--2.869.401.2511.64----
Boston Scientific Corporation12.68bn643.00m69.47bn41.00k108.57--41.255.480.44670.44678.81------------------68.8568.915.517.01--6.91----6.686.99-34.82-7.83----
Becton Dickinson and Co18.74bn1.49bn69.67bn77.00k47.492.7418.653.725.185.3065.3489.720.35193.128.40243,350.702.962.213.422.5144.7845.788.416.550.59956.320.392586.56-1.369.312.058.456.00--
Intuitive Surgical, Inc.6.22bn1.32bn90.00bn9.79k69.748.1069.8814.463.653.6517.1931.450.46912.747.21--10.1412.8611.4614.3467.4468.3021.6127.144.13------8.9714.67-22.435.99----
Data as of Feb 06 2023. Currency figures normalised to Becton Dickinson and Co's reporting currency: US Dollar USD

Institutional shareholders

38.14%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Sep 202224.07m8.47%
T. Rowe Price Associates, Inc. (Investment Management)as of 30 Sep 202220.84m7.33%
BlackRock Fund Advisorsas of 30 Sep 202214.06m4.95%
SSgA Funds Management, Inc.as of 30 Sep 202212.64m4.45%
Wellington Management Co. LLPas of 30 Sep 202210.93m3.84%
T. Rowe Price Investment Management, Inc.as of 30 Sep 20226.40m2.25%
Morgan Stanley Investment Management Ltd.as of 30 Sep 20226.34m2.23%
Massachusetts Financial Services Co.as of 30 Sep 20225.12m1.80%
Geode Capital Management LLCas of 30 Sep 20224.85m1.71%
Generation Investment Management LLPas of 30 Sep 20223.18m1.12%
More ▼
Data from 30 Sep 2022 - 30 Sep 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.